856165-89-4

Basic information

• Product Name: 3-chloro-4-(cyclopropylmethoxy)Benzoic acid
• Synonyms: 3-chloro-4-(cyclopropylmethoxy)Benzoic acid
• CAS NO: 856165-89-4
• Molecular Formula: C₁₁H₁₁ClO₃
• Molecular Weight: 226.65624
• Mol File: 856165-89-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-chloro-4-(cyclopropylmethoxy)Benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-4-(cyclopropylmethoxy)Benzoic acid(856165-89-4)
• EPA Substance Registry System: 3-chloro-4-(cyclopropylmethoxy)Benzoic acid(856165-89-4)

Safety Data

• Hazardous Substances Data: 856165-89-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-chloro-4-(cyclopropylmethoxy)benzoic acid is used as an intermediate in the development of new drugs for various medical conditions, leveraging its unique structural features to enhance drug efficacy and target specific biological pathways.
Used in Agrochemical Industry:
3-chloro-4-(cyclopropylmethoxy)benzoic acid is used as an intermediate in the production of herbicides and insecticides, contributing to the creation of effective crop protection agents that combat weeds and pests while ensuring crop yield and quality.

Upstream product

• 3964-57-6 methyl 4-hydroxy-3-chlorobenzoate 
• 7051-34-5 cyclopropylcarbinyl bromide 

Downstream Products

• 1192829-73-4 3-chloro-4-[(cyclopropylmethyl)oxy]benzoyl chloride 
• 1431532-93-2 tert-butyl ((2S)-1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-1,3-benzoxazol-6-yl)oxy)propan-2-yl)carbamate 
• 1431531-22-4 N-((2S)-1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-1,3-benzoxazol-6-yl)oxy)propan-2-yl)acetamide 
• 1192829-95-0 1,1-dimethylethyl 3-[5-(5-{3-chloro-4-[(cyclopropylmethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1-isoquinolinyl]propanoate 
• 1192829-51-8 3-[5-(5-{3-chloro-4-[(cyclopropylmethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1-isoquinolinyl]propanoic acid 
• 1431531-58-6 N-(1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-6-yl)oxy)propan-2-yl)acetamide 
• 1431533-82-2 6-(2-azidopropoxy)-2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazole 
• 1431533-81-1 1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-6-yl)oxy)propan-2-ol 
• 1431533-80-0 2-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-6-yl)oxy)-1-(morpholin-4-yl)ethanone 
• 1431533-79-7 2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-6-ol 
• 1431533-78-6 2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,7-dihydro-5H-spiro[1,3-benzoxazole-6,2'-[1,3]dioxolane] 
• 1431531-53-1 N-(1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-5-yl)oxy)propan-2-yl)acetamide 
• 1431533-75-3 5-(2-azidopropoxy)-2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazole 
• 1431533-74-2 1-((2-(3-chloro-4-(cyclopropylmethoxy)phenyl)-4,5,6,7-tetrahydro-1,3-benzoxazol-5-yl)oxy)propan-2-ol 

Relevant articles and documents

BICYCLIC COMPOUND

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

(3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS

The present invention encompasses compounds of Formula A: A as well as the pharmaceutically acceptable salts thereof. The compounds are S1P1/Edg1 receptor agonists and thus have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. The invention is also directed to pharmaceutical compositions containing such compounds and methods of treatment or prevention.